(Q56773016)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21760590%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

title

Role of BCL2L10 methylation and TET2 mutations in higher risk myelodysplastic syndromes treated with 5-azacytidine (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21760590%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21760590%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

Emiliano Fabiani

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21760590%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

Emanuele Angelucci

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21760590%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

Pellegrino Musto

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21760590%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

Marianna Criscuolo

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21760590%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

Luana Fianchi

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21760590%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

Marco Vignetti

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21760590%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

Valeria Santini

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21760590%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

Stefan Hohaus

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21760590%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

Giuseppe Leone

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21760590%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

author name string

A Piciocchi

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21760590%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

C Matteucci

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21760590%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

L Brandimarte

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21760590%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

C Finelli

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21760590%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

E Pogliani

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21760590%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

G Fioritoni

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21760590%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

M Greco

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21760590%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

C Mecucci

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21760590%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

publication date

15 July 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21760590%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21760590%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

volume

25

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21760590%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

issue

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21760590%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

page(s)

1910-1913

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21760590%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/leu.2011.170

7 February 2020

exact match

0 references

cites work

Mutation in TET2 in myeloid cancers

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.170

Detection of mutant TET2 in myeloid malignancies other than myeloproliferative neoplasms: CMML, MDS, MDS/MPN and AML.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.170

Genetic characterization of TET1, TET2, and TET3 alterations in myeloid malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.170

Impaired hydroxylation of 5-methylcytosine in myeloid cancers with mutant TET2

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.170

Valproic acid at therapeutic plasma levels may increase 5-azacytidine efficacy in higher risk myelodysplastic syndromes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.170

Efficacy of azacitidine compared with that of conventional care regimens in the treatment of higher-risk myelodysplastic syndromes: a randomised, open-label, phase III study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.170

Analysis of genome-wide methylation and gene expression induced by 5-aza-2'-deoxycytidine identifies BCL2L10 as a frequent methylation target in acute myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.170

TET2 mutation is an independent favorable prognostic factor in myelodysplastic syndromes (MDSs).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.170

Next-generation sequencing of the TET2 gene in 355 MDS and CMML patients reveals low-abundance mutant clones with early origins, but indicates no definite prognostic value

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.170

Reduction of phosphoinositide-phospholipase C beta1 methylation predicts the responsiveness to azacitidine in high-risk MDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.170

Myc sensitizes p53-deficient cancer cells to the DNA-damaging effects of the DNA methyltransferase inhibitor decitabine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.170

Loss of BCL2L10 protein expression as prognostic predictor for poor clinical outcome in gastric carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.170

Impact of TET2 mutations on response rate to azacitidine in myelodysplastic syndromes and low blast count acute myeloid leukemias

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.170

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/LEU.2011.170

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21760590%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

1 reference